BeStock  
Stocks › Biotechnology › MBX

MBX Biosciences MBX

US equityMarket cap rank #2559Biotechnology
$49.55 −$3.86 (-7.23%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $49.55 0.00%
Open$53.48
Prev close$53.41
Day range$49.36 – $54.43
Volume581.9K
Market cap$2.46B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$66.34M-177.3% YoY
Net profit-$62.42M-188.7% YoY
Diluted EPS-$1.29-104.8% YoY
Free cash flow-$36.07M-64.4% YoY
Operating cash flow-$34.88M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-15.6MDec '24$-23.9MMar '25$-19.4MJun '25$-21.6MSep '25$-22.1MDec '25$-23.5MMar '26$-37.1MJun '26$-62.4MSep '26

Diluted EPS by quarter

-0.47Dec '24-0.71Mar '25-0.58Jun '25-0.63Sep '25-0.49Dec '25-0.50Mar '26-0.78Jun '26-1.29Sep '26

Free cash flow by quarter

$-16.1MDec '24$-22.7MMar '25$-18.1MJun '25$-21.9MSep '25$-19.1MDec '25$-20.6MMar '26$-23.5MJun '26$-36.1MSep '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-33.7%
Return on assets-32.2%
Return on invested capital-37.1%
Current ratio19.58
Liabilities / assets5.5%
Cash & investments$481.59M
Total debt$2.50M
Net cash (debt)$479.09M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $66.34M $40.93M $27.27M $98.06M $25.80M
Selling and Admin Expenses $34.30M $9.95M $8.79M $18.90M $6.04M
-General & Admin Expense $34.30M $9.95M $8.79M $18.90M $6.04M
Research & Development $32.05M $30.99M $18.47M $79.16M $19.76M
Operating Profit -$66.34M -$40.93M -$27.27M -$98.06M -$25.80M
Net Non-Operating Interest Income (Expense) $3.92M $3.84M $3.75M $11.08M $3.73M
Non-Operating Interest Income $3.92M $3.84M $3.75M $11.08M $3.73M
Pretax Profit -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Net Profit -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Profit from Continuing Operations -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Net Income to Parent Company -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Net Income to Common Stockholders -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Basic EPS -$1.29 -$0.78 -$0.50 -$2.38 -$0.49
Diluted EPS -$1.29 -$0.78 -$0.50 -$2.38 -$0.49

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $500.62M $435.91M $452.70M $385.14M $385.14M
Total Current Assets $492.76M $427.86M $448.54M $381.54M $381.54M
Cash and Cash Equivalents & Short-Term Investments $481.59M $418.58M $439.98M $373.71M $373.71M
-Cash and Cash Equivalents $161.69M $54.12M $45.21M $75.29M $75.29M
-Short Term Investments $319.90M $364.46M $394.76M $298.42M $298.42M
Receivables $3.23M $3.04M $3.16M $2.12M $2.12M
-Accrued Interest Receivable $3.23M $3.04M $3.16M $2.12M $2.12M
Prepaid Assets $5.45M $5.07M $4.59M $4.85M $4.85M
Other Current Assets $2.48M $1.16M $814,000.00 $861,000.00 $861,000.00
Total Non-Current Assets $7.86M $8.05M $4.17M $3.61M $3.61M
Net PPE $7.61M $7.42M $3.59M $3.22M $3.22M
-Gross PPE $8.56M $8.24M $4.32M $3.89M $3.89M
-Accumulated Depreciation -$952,000.00 -$813,000.00 -$734,000.00 -$670,000.00 -$670,000.00
Non-Current Prepaid Assets $42,000.00 $42,000.00 $42,000.00 $42,000.00 $42,000.00
Non-Current Deferred Assets $0.00 $378,000.00 $332,000.00 $341,000.00 $341,000.00
Other Non-Current Assets $205,000.00 $205,000.00 $205,000.00 – –
Total Liabilities $27.67M $26.37M $14.95M $15.92M $15.92M
Total Current Liabilities $25.17M $23.66M $14.57M $15.50M $15.50M
Payables $6.81M $4.36M $6.97M $2.98M $2.98M
-Accounts Payable $6.81M $4.36M $6.97M $2.98M $2.98M
Current Accrued Expenses $11.99M $14.06M $5.08M $8.03M $8.03M
Short-Term Debt and Capital Lease Obligation $787,000.00 $631,000.00 $178,000.00 $172,000.00 $172,000.00
-Current Capital Lease Obligation $787,000.00 $631,000.00 $178,000.00 $172,000.00 $172,000.00
Total Non-Current Liabilities $2.50M $2.71M $378,000.00 $426,000.00 $426,000.00
Long Term Debt and Capital Lease Obligation $2.50M $2.71M $377,000.00 $424,000.00 $424,000.00
-Long Term Capital Lease Obligation $2.50M $2.71M $377,000.00 $424,000.00 $424,000.00
Total Equity $472.95M $409.54M $437.76M $369.22M $369.22M
Stockholders' Equity $472.95M $409.54M $437.76M $369.22M $369.22M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $822.41M $695.84M $686.35M $593.41M $593.41M
Retained Earnings -$347.51M -$285.09M -$247.99M -$224.48M -$224.48M
Gains/Losses Not Affecting Retained Earnings -$1.96M -$1.22M -$606,000.00 $286,000.00 $286,000.00
Other Non-Current Liabilities – – $1,000.00 $2,000.00 $2,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$34.88M -$22.62M -$20.21M -$79.95M -$18.30M
Net cash flow from continuing operations -$34.88M -$22.62M -$20.21M -$79.95M -$18.30M
Net Income from Continuing Operations -$62.42M -$37.10M -$23.52M -$86.97M -$22.06M
Depreciation & Depletion & Amortization $140,000.00 $79,000.00 $64,000.00 $248,000.00 $60,000.00
Other Non-Cash Items $149,000.00 $120,000.00 $34,000.00 $133,000.00 $32,000.00
Change in Working Capital -$84,000.00 $8.63M -$1.69M $1.58M $1.57M
-Change in Prepaid Assets -$2.10M $258,000.00 -$725,000.00 -$2.70M -$2.01M
-Change in Payables and Accrued Expense $2.07M $7.97M -$885,000.00 $4.34M $3.59M
-Change in Other Current Assets $0.00 -$2.38M -$43,000.00 -$493,000.00 $8,000.00
-Change in Other Current Liabilities -$49,000.00 $2.79M -$41,000.00 $425,000.00 -$27,000.00
Net cash flow from investing $42.83M $29.21M -$97.10M -$83.71M -$129.97M
Net Cash Flow from Continuing Investing Activities $42.83M $29.21M -$97.10M -$83.71M -$129.97M
Net PPE Purchase and Sale -$1.19M -$901,000.00 -$437,000.00 -$1.93M -$793,000.00
Net Investment Purchase and Sale $44.02M $30.11M -$96.66M -$81.78M -$129.18M
Financing Cash Flow $99.61M $2.32M $87.44M $189.59M $438,000.00
Net Cash Flow from Continuing Financing Activities $99.61M $2.32M $87.44M $189.59M $438,000.00
Net Common Stock Issuance $97.24M $254,000.00 $85.37M $187.95M $0.00
Proceeds from Stock Option Exercised $2.41M $2.19M $2.44M $2.42M $955,000.00
Net Other Financing Charges -$31,000.00 -$127,000.00 -$378,000.00 -$771,000.00 -$517,000.00
Ending Cash Balance $161.90M $54.33M $45.42M $75.29M $75.29M
Net Change in Cash $107.57M $8.91M -$29.87M $25.94M -$147.84M
Beginning Cash Balance $54.33M $45.42M $75.29M $49.35M $223.13M
Free Cash Flow -$36.07M -$23.52M -$20.65M -$81.88M -$19.09M
Net Preferred Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on MBX.

Sign in to join the discussion.

Scroll to Top